ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
KI_DrugDev_report_merge_17th_July_2019 .docx (4.4 MB)
0/0

Towards Academic Drug Development Guidelines

preprint
revised on 16.07.2019 and posted on 17.07.2019 by Christopher Southan
This report covers academic small-molecule drug development with a view to distilling guidelines. The first section covers research productivity feeding into commercial development before reviewing the literature on statistics of academic development It then considers differences between probes and drugs before discussing the role of author guidelines in medicinal chemistry and pharmacology journals. Resources for comprehensive compound and target cross-checking are then covered followed by comparisons between public and commercial databases including case studies of selected compounds. It concludes with an outline of new scientific developments that could increase the success rate of academic drug development.

History

Email Address of Submitting Author

cdsouthan@gmail.com

Institution

TW2Informatics

Country

Sweden

ORCID For Submitting Author

0000-0001-9580-0446

Declaration of Conflict of Interest

No conflict of interest

Version Notes

Version of 17th July

Licence

Exports

Logo branding

Licence

Exports